BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 8, 2012
View Archived Issues
Verva reports on proof-of-concept trial of repurposed drug
Read More
Spanish scientists discover new integrin antagonists
Read More
Janssen Pharmaceuticals presents novel mGlu2 receptor modulators
Read More
Actelion Pharmaceuticals synthesizes novel orexin receptor antagonists
Read More
Novel mineralocorticoid receptor antagonists presented
Read More
Janssen and Medivir develop novel agents for hepatitis
Read More
Gene therapy for choroideremia enters clinic
Read More
AstraZeneca TLR7 agonist assessed in four clinical trials
Read More
AX-01128 protects kidney transplant function in vivo
Read More
Researchers at the CNRS disclose novel inhibitors of tubulin polymerization
Read More
Amorfix licenses diagnostic test for Alzheimer's disease to JSW Life Sciences
Read More
FDA grants fast track designation to NKTR-181
Read More
Takeda transfers TAK-070 to university
Read More
Arrowhead Research prepares to file IND
Read More
FDA approves Horizant for new indication
Read More
Alnylam completes enrollment in phase I ALN-TTR02 study and begins phase II trial
Read More
Astellas makes first Dificlir sales in Europe, triggering milestone payment to Optimer
Read More
Trovagene and Strand Life Sciences enter collaboration in India and South Asia
Read More
U.K.'s NICE issues preliminary opinion on cost-effectiveness of Bronchitol for cystic fibrosis
Read More
Ongoing EULAR conference features long-term adalimumab efficacy data in spondylarthritis
Read More
FDA extends regulatory review period for ultralong-acting insulins
Read More
Sorrento Therapeutics receives new NIH grant
Read More
Mesoblast outlines plans to develop stem cell therapies for neurodegenerative diseases
Read More
AR-42 gets E.U. orphan drug status for two additional indications
Read More
Researchers describe novel monovalent CD28-targeted Fab' antibody fragment
Read More
